PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced positive results from an interim analysis of the TANGO-2 trial of its fixed-dose, investigational antibiotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback